← Leaderboards
Jessica J Kandel
Columbia University Health Sciences
$2,178,519
Attributed
$2,883,837
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $459.6K · FY2005–14$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,883,837 · 4
By mechanism
R01$1,612,383 · 1
R21$1,271,454 · 3
Top collaborators
- Mark Andrew Borden4 shared
- Carrie J. Shawber2 shared
- Shashank Ramesh Sirsi2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Peter D Canoll$11,470,200
- Benjamin Tycko$19,558,566
- Wendy K Chung$27,581,365
- Jianzhong Huang$669,480
- Yufeng Shen$10,499,570
Others in their field
Top investigators on “Histology”
- David Heimbrook · Leidos Biomedical Research, Inc.$101,247,600
- Ed Lein · Allen Institute$41,433,793
- Richard A McIndoe · Augusta University$40,237,070
- Paul A Bunn · University Of Colorado Denver$40,003,395
- Hongkui Zeng · Allen Institute$37,381,292
- Robert H Mach · Wake Forest University$32,134,840
Research focus
HistologyChildBlood VesselsTumorIn VivoResponseVascular Endothelial Growth FactorsAngiogenesisImageUltrasonographyContrast MediaMonitorGene ExpressionDesignPre-ClinicalTissuesMolecular ImagingMethodologyDiagnosticExhibitsMolecularBiomedical EngineeringArchitectureInnovation
Grant awards (11)
Concurrent ultrasound & molecular evaluation of a lymphatic malformation model$194,000
R21 · FY2014 · EB
Concurrent ultrasound & molecular evaluation of a lymphatic malformation model$240,000
R21 · FY2013 · EB
Quantitative Monitoring and Control of Tumor Vascular Permeability in vivo Using$219,637
R21 · FY2013 · EB
Quantitative Monitoring and Control of Tumor Vascular Permeability in vivo Using$197,908
R21 · FY2012 · EB
COMBINED ULTRASOUND/MOLECULAR ANALYSIS OF TUMOR RESPONSE TO VEGF BLOCKADE$228,214
R21 · FY2010 · CA
COMBINED ULTRASOUND/MOLECULAR ANALYSIS OF TUMOR RESPONSE TO VEGF BLOCKADE$191,695
R21 · FY2009 · CA
Acquired Resistance to VEGF blockade in Wilms tumor$310,442
R01 · FY2007 · CA · contact PI
Acquired Resistance to VEGF blockade in Wilms tumor$319,714
R01 · FY2006 · CA · contact PI
Acquired Resistance to VEGF blockade in Wilms tumor$327,409
R01 · FY2005 · CA
Acquired Resistance to VEGF blockade in Wilms tumor$327,409
R01 · FY2004 · CA
Acquired Resistance to VEGF blockade in Wilms tumor$327,409
R01 · FY2003 · CA